StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck organon Revenue — United States ($M) ($M)

Organon & Co. Form 10-Q / 10-K

QuarterlyAnnual
Latest, FY2025
1,604,000,000
Period ended Dec 31, 2025
Change on a year earlier
+2.0%
1,572,000,000 in FY2024
History
7 years
Since FY2019
Sources
4
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOrganon Revenue — United States ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,604,000,000+2.0%Organon & Co. SEC Filing (0001628280-26-011125) ↗
FY2024Dec 31, 20241,572,000,000+6.4%Organon & Co. SEC Filing (0001821825-25-000006) ↗
FY2023Dec 31, 20231,478,000,000+2.9%Organon & Co. SEC Filing (0001821825-25-000006) ↗
FY2022Dec 31, 20221,437,000,000+3.9%Organon & Co. SEC Filing (0001821825-25-000006) ↗
FY2021Dec 31, 20211,383,000,000-1.8%Organon & Co. SEC Filing (0001821825-23-000003) ↗
FY2020Dec 31, 20201,408,000,000-30.3%Organon & Co. SEC Filing (0001821825-23-000003) ↗
FY2019Dec 31, 20192,021,000,000–Organon & Co. SEC Filing (0001821825-22-000002) ↗

Cite this data

StockData. (2026). Merck Organon Revenue — United States ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/ogn_geo_us

See every metric in the Merck KPI table. Data updated Oct 26, 2026.